Connor Clark & Lunn Investment Management Ltd. Acquires New Position in Aveanna Healthcare Holdings Inc. $AVAH

Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the 2nd quarter, HoldingsChannel reports. The firm acquired 919,627 shares of the company’s stock, valued at approximately $7,881,000.

A number of other large investors have also recently bought and sold shares of AVAH. Landscape Capital Management L.L.C. bought a new position in shares of Aveanna Healthcare during the second quarter valued at approximately $102,000. C M Bidwell & Associates Ltd. acquired a new stake in shares of Aveanna Healthcare during the 2nd quarter worth approximately $69,000. NFJ Investment Group LLC bought a new stake in shares of Aveanna Healthcare in the 2nd quarter worth approximately $2,682,000. Virtus Advisers LLC bought a new stake in shares of Aveanna Healthcare in the 2nd quarter worth approximately $363,000. Finally, BlackRock Inc. acquired a new position in Aveanna Healthcare during the 2nd quarter valued at approximately $63,504,000. Institutional investors own 87.96% of the company’s stock.

Insider Transactions at Aveanna Healthcare

In other news, major shareholder Robert M. Williams, Jr. sold 14,500,002 shares of the stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $166,750,023.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 12,496,077 shares of the firm’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $143,704,885.50. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 79,746,745 shares of company stock valued at $773,117,091. 5.30% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Barclays upped their price objective on Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a research note on Thursday, July 9th. Raymond James Financial boosted their price target on shares of Aveanna Healthcare from $13.00 to $15.00 and gave the company a “strong-buy” rating in a report on Friday, August 14th. Royal Bank Of Canada upped their price target on shares of Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a research report on Monday. Wall Street Zen cut shares of Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Thursday, July 2nd. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $12.89.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH opened at $13.62 on Thursday. Aveanna Healthcare Holdings Inc. has a 12-month low of $5.93 and a 12-month high of $13.98. The company has a market cap of $2.97 billion, a PE ratio of 11.07, a P/E/G ratio of 0.85 and a beta of 1.90. The stock has a 50 day simple moving average of $9.95 and a 200-day simple moving average of $8.03. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.17 by $0.05. The firm had revenue of $670.48 million for the quarter, compared to analysts’ expectations of $638.61 million. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%. On average, equities research analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.75 EPS for the current year.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.